Abstract
Pharmaceutical manufacturers producing or distributing drugs in Canada were surveyed between December 1974 and March 1975 to determine which of their products contained tartrazine, a pyrazole aniline dye. A list of some 580 drug products of the 156 manufacturers who responded is presented for aid in managing the tartrazine-sensitive patients.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Michaëlsson G., Juhlin L. Urticaria induced by preservatives and dye additives in food and drugs. Br J Dermatol. 1973 Jun;88(6):525–532. doi: 10.1111/j.1365-2133.1973.tb08014.x. [DOI] [PubMed] [Google Scholar]
- Parker C. W. Drug therapy. During allergy (third of three parts). N Engl J Med. 1975 May 1;292(18):957–960. doi: 10.1056/NEJM197505012921806. [DOI] [PubMed] [Google Scholar]
- Samter M., Beers R. F., Jr Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann Intern Med. 1968 May;68(5):975–983. doi: 10.7326/0003-4819-68-5-975. [DOI] [PubMed] [Google Scholar]
- Smith A. P. Response of aspirin-allergic patients to challenge by some analgesics in common use. Br Med J. 1971 May 29;2(5760):494–496. doi: 10.1136/bmj.2.5760.494. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Speer F. Aspirin allergy: a clinical study. South Med J. 1975 Mar;68(3):314–318. doi: 10.1097/00007611-197503000-00013. [DOI] [PubMed] [Google Scholar]